Future Science Group

OCTalks: Promising results for metastatic TNBC - exploring the TONIC trial

Informações:

Synopsis

In this podcast discover details of the TONIC trial which has yielded promising response rates in patients with metastatic triple-negative breast cancer treated with nivolumab after induction treatment.